Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 24

1.

Hepcidin: immunoanalytic characteristics.

Wolff F, de Verneuil H, Rucheton B, Lefebvre T, Vialaret J, Ropert-Bouchet M, Cunat S, Aguilar-Martinez P, Lehmann S, Delaby C.

Ann Biol Clin (Paris). 2018 Dec 1;76(6):705-715. doi: 10.1684/abc.2018.1382. Review.

PMID:
30257815
2.

Inherited or acquired modifiers of iron status may dramatically affect the phenotype in dehydrated hereditary stomatocytosis.

Orvain C, Da Costa L, Van Wijk R, Pissard S, Picard V, Mansour-Hendili L, Cunat S, Giansily-Blaizot M, Cartron G, Schved JF, Aguilar-Martinez P.

Eur J Haematol. 2018 Oct;101(4):566-569. doi: 10.1111/ejh.13135. Epub 2018 Aug 31.

PMID:
29969830
3.

Added value of hepcidin quantification for the diagnosis and follow-up of anemia-related diseases.

Lefebvre T, Lasocki S, Fénéant-Thibault M, Lamy PJ, Cunat S, Ropert-Bouchet M, Aguilar-Martinez P, Lehmann S, Delaby C.

Ann Biol Clin (Paris). 2017 Feb 1;75(1):9-18. doi: 10.1684/abc.2016.1208. Review.

PMID:
28132948
4.

[Pseudoxanthoma elasticum-like disease with deficiency of vitamin K-dependent clotting factors and cutis laxa features].

Gusdorf L, Mitcov M, Maradeix S, Cunat S, Martin L, Cribier B.

Ann Dermatol Venereol. 2016 Apr;143(4):279-83. doi: 10.1016/j.annder.2015.11.010. Epub 2016 Mar 2. French.

PMID:
26944767
5.

The role of genetic factors in patients with hepatocellular carcinoma and iron overload - a prospective series of 234 patients.

Funakoshi N, Chaze I, Alary AS, Tachon G, Cunat S, Giansily-Blaizot M, Bismuth M, Larrey D, Pageaux GP, Schved JF, Donnadieu-Rigole H, Blanc P, Aguilar-Martinez P.

Liver Int. 2016 May;36(5):746-54. doi: 10.1111/liv.12984. Epub 2015 Nov 7.

PMID:
26474245
6.

Variable age of onset and clinical severity in transferrin receptor 2 related haemochromatosis: novel observations.

Bardou-Jacquet E, Cunat S, Beaumont-Epinette MP, Kannengiesser C, Causse X, Sauvion S, Pouliquen B, Deugnier Y, David V, Loréal O, Aguilar-Martinez P, Brissot P, Jouanolle AM.

Br J Haematol. 2013 Jul;162(2):278-81. doi: 10.1111/bjh.12350. Epub 2013 Apr 18. No abstract available.

PMID:
23600741
7.

Homozygous mutation of the 5'UTR region of the L-Ferritin gene in the hereditary hyperferritinemia cataract syndrome and its impact on the phenotype.

Giansily-Blaizot M, Cunat S, Moulis G, Schved JF, Aguilar-Martinez P.

Haematologica. 2013 Apr;98(4):e42-3. doi: 10.3324/haematol.2012.077198. Epub 2013 Jan 8. No abstract available.

8.

Porphyria cutanea tarda and spherocytosis: a non-random association?

Du-Thanh A, Aguilar-Martinez P, Enescu C, Cunat S, Guillot B, Dereure O.

Acta Derm Venereol. 2013 May;93(3):377-8. doi: 10.2340/00015555-1493. No abstract available.

9.

Absence of functional mutations in the ferroportin-encoding SLC40A1 gene in porphyria cutanea tarda: a series of 37 cases from southern France.

Du Thanh A, Martinez P, Cunat S, Bessis D, Guillot B, Dereure O.

Acta Derm Venereol. 2011 Jun;91(4):467. doi: 10.2340/00015555-0987. No abstract available.

10.

Iron overload in HFE C282Y heterozygotes at first genetic testing: a strategy for identifying rare HFE variants.

Aguilar-Martinez P, Grandchamp B, Cunat S, Cadet E, Blanc F, Nourrit M, Lassoued K, Schved JF, Rochette J.

Haematologica. 2011 Apr;96(4):507-14. doi: 10.3324/haematol.2010.029751. Epub 2011 Jan 12.

11.

Hemojuvelin and hepcidin gene mutations in patients with porphyria cutanea tarda from Southern France.

Du Thanh A, Aguilar-Martinez P, Cunat S, Bessis D, Guillot B, Dereure O.

Acta Derm Venereol. 2011 Jan;91(1):66-7. doi: 10.2340/00015555-0853. No abstract available.

12.

The Southern French registry of genetic hemochromatosis: a tool for determining clinical prevalence of the disorder and genotype penetrance.

Aguilar-Martinez P, Bismuth M, Blanc F, Blanc P, Cunat S, Dereure O, Dujols P, Giansily-Blaizot M, Jorgensen C, Konate A, Larrey D, Le Quellec A, Mura T, Raingeard I, Ramos J, Renard E, Rousseau F, Schved JF, Picot MC.

Haematologica. 2010 Apr;95(4):551-6. doi: 10.3324/haematol.2009.014431. Epub 2010 Feb 9.

13.

HAMP promoter mutation nc.-153C>T in non p.C282Y homozygous patients with iron overload.

Aguilar-Martinez P, Giansily-Blaizot M, Bismuth M, Cunat S, Igual H, Schved JF.

Haematologica. 2010 Apr;95(4):687-8. doi: 10.3324/haematol.2009.018028. Epub 2009 Dec 8. No abstract available.

14.

The cell cycle control protein cdc25C is present, and phosphorylated on serine 214 in the transition from germinal vesicle to metaphase II in human oocyte meiosis.

Cunat S, Anahory T, Berthenet C, Hedon B, Franckhauser C, Fernandez A, Hamamah S, Lamb NJ.

Mol Reprod Dev. 2008 Jul;75(7):1176-84.

PMID:
18161793
15.

Global sequencing approach for characterizing the molecular background of hereditary iron disorders.

Cunat S, Giansily-Blaizot M, Bismuth M, Blanc F, Dereure O, Larrey D, Quellec AL, Pouderoux P, Rose C, Raingeard I, Renard E, Schved JF, Aguilar-Martinez P; CHU Montpellier AOI 2004 Working Group.

Clin Chem. 2007 Dec;53(12):2060-9. Epub 2007 Oct 19.

16.

A novel mutation of the beta-globin gene promoter (-102 C>A) and pitfalls in family screening.

Aguilar-Martinez P, Jourdan E, Brun S, Cunat S, Giansily-Blaizot M, Pissard S, Schved JF.

Am J Hematol. 2007 Dec;82(12):1088-90.

17.

Juvenile hemochromatosis caused by a novel combination of hemojuvelin G320V/R176C mutations in a 5-year old girl.

Aguilar-Martinez P, Lok CY, Cunat S, Cadet E, Robson K, Rochette J.

Haematologica. 2007 Mar;92(3):421-2.

18.

Aromatase expression in ovarian epithelial cancers.

Cunat S, Rabenoelina F, Daurès JP, Katsaros D, Sasano H, Miller WR, Maudelonde T, Pujol P.

J Steroid Biochem Mol Biol. 2005 Jan;93(1):15-24.

PMID:
15748828
19.

Letrozole sensitizes breast cancer cells to ionizing radiation.

Azria D, Larbouret C, Cunat S, Ozsahin M, Gourgou S, Martineau P, Evans DB, Romieu G, Pujol P, Pèlegrin A.

Breast Cancer Res. 2005;7(1):R156-63. Epub 2004 Dec 7.

20.

Estrogens and epithelial ovarian cancer.

Cunat S, Hoffmann P, Pujol P.

Gynecol Oncol. 2004 Jul;94(1):25-32. Review.

PMID:
15262115
21.

Abstracts from the 8th Annual Meeting of the Scientific Association of Swiss Radiation Oncology (SASRO).

Allal AS, Ares C, Dulguerov P, Tschanz E, Verdan C, Mhawech P, Riesterer O, Honer M, Vuong V, Jochum W, Zingg D, Bodis S, Ametamey S, Pruschy M, Inteeworn N, Ohlerth S, Höpfl G, Roos M, Wergin M, Rohrer Bley C, Gassmann M, Kaser-Hotz B, Berthou S, Aebersold DM, Ganapathipillai S, Streit B, Stalder D, Gruber G, Greiner RH, Zimmer Y, Lutters G, Krek W, Tenzer A, Hofstetter B, Bonny C, Azria A, Larbouret C, Cunat S, Ozsahin M, Zouhair A, Gourgou S, Martineau P, Evans DB, Romieu G, Pujol P, Pèlegrin A, Heuberger J, Kestenholz P, Taverna Ch, Lardinois D, Jörger M, Schneiter D, Jerman M, Weder W, Stahel R, Bodis S, Vees H, Mach N, Hügli A, Balmer Majno S, Beer KT, Friedrich EE, Ciernik IF, Stanek N, Taverna C, Greiner R, Mahler F, Landmann Ch, Studer G, Bernier J, Gallino A, Juelke PD, Hafner HP, Jamshidi P, Erne P, Resink TJ, Thum P, Notter M, Bargetzi M, Suleiman M, Luthi JC, Bieri S, Curschmann J, Pajic B, Kranzbühler H, Lippold B, Ueltschi G, Bonetti M, Nasi ML, Price KN, Castiglione-Gertsch M, Rudenstam CM, Holmberg SB, Lindtner J, Gol-Ouh R, Collins J, Crivellari D, Carbone A, Thürlimann B, Simoncini E, Fey MF, Gelber RD, Coates AS, Goldhirsch A, Jeanneret Sozzi W, Kramar A, Mirimanoff RO, Azria D, Taussky D, Becker M, Kranzbuehler H, Weitzel M, Bortoluzzi L, Behrensmeier F, Isaak B, Pasche P, Luthi F, Weber DC, Lomax AJ, Rutz HP, Pedroni ES, Verwey J, Goitein G, Timmermann B, Lomax A, Bolsi A, Weber D, Bentzen SM, Khalil AA, Saunders MI, Horiot JC, Van den Bogaert W, Cummings BJ, Dische S, Slosman DO, Kebdani T, Allaoua M, Stadelmann O, Stupp R, Pica A, Dubois JB, Oehler C, Ulmer U, Lütolf UM, Huser M, Burger C, Szekely G, Davis JB, Gervaz P, Gertsch P, Morel P, Roth AD, Zenklusen H, Schott A, Curti G, Schefer H, Kolotas C, Thalmann G, Vetterli D, Kemmerling L, Mini R, Rouzaud M, Nouet P, Mollà M, Escudé L, Miralbell R, Beer K, von Briel C, Jichlinski P, Guillou L, Fogliata A, Nicolini G, Cozzi L, Hafner HP, Hueber P, Szczerba D, Born EJ, Dipasquale G, Jargy C, Munier F, Balmer A, Do HP, Pasche G, Wang H, Moeckli R, Boehringer T, Coray A, Lin S, Pedroni E, Rutz H, Baumert BG, Norton IA, Schoenmaker E, Krayenbühl J, Bründler MA, Allemann K, Laluhovà D, Collen T, Coucke P, Ries G, Rufibach K, Huguenin P, Abdou M, Girardet C, Vees HJ, Bigler R, Özsoy O, Bouville S, Corminboeuf F, Betz M, Matzinger O, Tebeu P, Popowski Y, Verkooijen H, Bouchardy C, Ludicke F, Usel M, Major A, Merçay A, Pache G, Bulling S, Bressan S, Valley JF, Motta M, Presilla S, Richetti A, Franzetti A, Pesce G.

Strahlenther Onkol. 2004 Jun;180 Suppl 1:89-108. doi: 10.1007/BF03356735. No abstract available.

PMID:
27137923
22.

Estrogen regulated proteases and antiproteases in ovarian and breast cancer cells.

Rochefort H, Chalbos D, Cunat S, Lucas A, Platet N, Garcia M.

J Steroid Biochem Mol Biol. 2001 Jan-Mar;76(1-5):119-24. Review.

PMID:
11384869
23.

Unliganded and liganded estrogen receptors protect against cancer invasion via different mechanisms.

Platet N, Cunat S, Chalbos D, Rochefort H, Garcia M.

Mol Endocrinol. 2000 Jul;14(7):999-1009.

PMID:
10894150
24.

Estrogen receptor mediated inhibition of cancer cell invasion and motility: an overview.

Rochefort H, Platet N, Hayashido Y, Derocq D, Lucas A, Cunat S, Garcia M.

J Steroid Biochem Mol Biol. 1998 Apr;65(1-6):163-8. Review.

PMID:
9699869

Supplemental Content

Support Center